scispace - formally typeset
C

Constanze Schönemann

Researcher at Charité

Publications -  69
Citations -  3663

Constanze Schönemann is an academic researcher from Charité. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 26, co-authored 69 publications receiving 3405 citations. Previous affiliations of Constanze Schönemann include Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

TL;DR: A non-HLA, AT1-receptor-mediated pathway may contribute to refractory vascular rejection, and affected patients might benefit from removal of At1- receptor antibodies or from pharmacologic blockade of AT1 receptors.
Journal ArticleDOI

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

TL;DR: It is confirmed that HLAab produced even late after transplantation are detrimental to graft outcome, and DSA were proven to have a strong adverse impact on graft survival.
Journal ArticleDOI

Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.

TL;DR: The results confirmed the previous contention that HCMV IE‐1 is an important CD8 T cell target and the technical improvement made in order to address this question has clearly wider implications.
Journal ArticleDOI

Donor‐Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation

TL;DR: It is demonstrated for the first time that everolimus‐based immunosuppression is associated with an increased risk for the development of DSA and AMR.